D. Hunter Best

1.1k total citations
25 papers, 515 citations indexed

About

D. Hunter Best is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, D. Hunter Best has authored 25 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in D. Hunter Best's work include Pulmonary Hypertension Research and Treatments (8 papers), Liver physiology and pathology (5 papers) and Genomics and Rare Diseases (4 papers). D. Hunter Best is often cited by papers focused on Pulmonary Hypertension Research and Treatments (8 papers), Liver physiology and pathology (5 papers) and Genomics and Rare Diseases (4 papers). D. Hunter Best collaborates with scholars based in United States, Ireland and United Kingdom. D. Hunter Best's co-authors include William B. Coleman, C. Gregory Elliott, Pınar Bayrak‐Toydemir, A. Kocer, Judith Reichmann, Ian R. Adams, Wendy K. Chung, Eric D. Austin, Lynette Brown and Rong Mao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and CHEST Journal.

In The Last Decade

D. Hunter Best

23 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Hunter Best United States 11 238 163 113 108 95 25 515
Audrey Cleuren United States 10 40 0.2× 149 0.9× 50 0.4× 48 0.4× 57 0.6× 30 545
B. Teisner Denmark 7 92 0.4× 201 1.2× 101 0.9× 51 0.5× 17 0.2× 8 409
Benoit Destenaves United Kingdom 11 81 0.3× 175 1.1× 115 1.0× 84 0.8× 27 0.3× 15 544
Chelsea C. Estrada United States 10 80 0.3× 189 1.2× 90 0.8× 35 0.3× 17 0.2× 15 436
W. L. Williams United States 13 167 0.7× 116 0.7× 18 0.2× 44 0.4× 25 0.3× 17 422
Susanne Müller Germany 10 106 0.4× 290 1.8× 54 0.5× 125 1.2× 14 0.1× 28 572
Stéphanie Brayer France 9 247 1.0× 296 1.8× 44 0.4× 55 0.5× 10 0.1× 13 561
Simon C. Rowan Ireland 11 270 1.1× 158 1.0× 48 0.4× 72 0.7× 45 0.5× 17 426
Wen‐Jie Wang China 12 98 0.4× 106 0.7× 16 0.1× 68 0.6× 12 0.1× 35 378
Šárka Svobodová Czechia 13 61 0.3× 75 0.5× 12 0.1× 26 0.2× 27 0.3× 27 299

Countries citing papers authored by D. Hunter Best

Since Specialization
Citations

This map shows the geographic impact of D. Hunter Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hunter Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hunter Best more than expected).

Fields of papers citing papers by D. Hunter Best

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Hunter Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hunter Best. The network helps show where D. Hunter Best may publish in the future.

Co-authorship network of co-authors of D. Hunter Best

This figure shows the co-authorship network connecting the top 25 collaborators of D. Hunter Best. A scholar is included among the top collaborators of D. Hunter Best based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Hunter Best. D. Hunter Best is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Robert G., et al.. (2023). Rapid Whole Genome Sequencing in Critically Ill Newborns. 6(1). 175–186.
2.
Pedersen, Brent S., Joe Brown, Harriet Dashnow, et al.. (2021). Effective variant filtering and expected candidate variant yield in studies of rare human disease. npj Genomic Medicine. 6(1). 60–60. 60 indexed citations
3.
Kapron, Ashley L., D. Hunter Best, Mary Anne Karren, et al.. (2021). Addressing ethical and laboratory challenges for initiation of a rapid whole genome sequencing program. SHILAP Revista de lepidopterología. 5(1). e177–e177. 2 indexed citations
4.
Day, Ronald W., et al.. (2016). Pulmonary veno-occlusive disease: Two children with gradual disease progression. Respiratory Medicine Case Reports. 20. 82–86. 2 indexed citations
5.
Best, D. Hunter, Kelli Sumner, Benjamin P. Smith, et al.. (2016). EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension. CHEST Journal. 151(4). 821–828. 51 indexed citations
6.
McGovern, Eiméar, Paul McNally, Maureen J. O’Sullivan, et al.. (2015). Infantile pulmonary capillary haemangiomatosis: a lethal form of pulmonary hypertension. Cardiology in the Young. 26(4). 663–668. 1 indexed citations
7.
Chung, Wendy K., Eric D. Austin, D. Hunter Best, Lynette Brown, & C. Gregory Elliott. (2014). When to Offer Genetic Testing for Pulmonary Arterial Hypertension. Canadian Journal of Cardiology. 31(4). 544–547. 9 indexed citations
8.
Sumner, Kelli, Jeffrey Swensen, Melinda Procter, et al.. (2014). Noncontinuously Binding Loop-Out Primers for Avoiding Problematic DNA Sequences in PCR and Sanger Sequencing. Journal of Molecular Diagnostics. 16(5). 477–480. 3 indexed citations
9.
Best, D. Hunter, Eric D. Austin, Wendy K. Chung, & C. Gregory Elliott. (2014). Genetics of pulmonary hypertension. Current Opinion in Cardiology. 29(6). 520–527. 29 indexed citations
10.
Best, D. Hunter, Kelli Sumner, Eric D. Austin, et al.. (2013). EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis. CHEST Journal. 145(2). 231–236. 135 indexed citations
11.
Ridge, Perry G., Christine Miller, Pınar Bayrak‐Toydemir, et al.. (2013). Cystic fibrosis testing in a referral laboratory: results and lessons from a six-year period. PubMed. 3(1). 3–3. 2 indexed citations
12.
Smith, Benjamin P., D. Hunter Best, & C. Gregory Elliott. (2012). Genetics and Pharmacogenomics in Pulmonary Arterial Hypertension. Heart Failure Clinics. 8(3). 319–330. 1 indexed citations
13.
Best, D. Hunter & William B. Coleman. (2011). Activation and Regulation of Reserve Liver Progenitor Cells. Vitamins and hormones. 87. 93–109. 4 indexed citations
14.
Best, D. Hunter, Cecily P. Vaughn, Jamie McDonald, et al.. (2011). Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients. Journal of Medical Genetics. 48(5). 358–360. 28 indexed citations
15.
Best, D. Hunter & William B. Coleman. (2010). Liver regeneration by small hepatocyte-like progenitor cells after necrotic injury by carbon tetrachloride in retrorsine-exposed rats. Experimental and Molecular Pathology. 89(2). 92–98. 11 indexed citations
17.
Mosse, Claudio A., et al.. (2009). A B-Cell Lymphoma Diagnosed in “Floater” Tissue: Implications of the Diagnosis and Resolution of a Laboratory Error. The American Journal of the Medical Sciences. 338(3). 248–251. 4 indexed citations
18.
Best, D. Hunter, et al.. (2009). Cytokine-dependent activation of small hepatocyte-like progenitor cells in retrorsine-induced rat liver injury. Experimental and Molecular Pathology. 88(1). 7–14. 8 indexed citations
19.
Kocer, A., Judith Reichmann, D. Hunter Best, & Ian R. Adams. (2009). Germ cell sex determination in mammals. Molecular Human Reproduction. 15(4). 205–213. 80 indexed citations
20.
Best, D. Hunter & William B. Coleman. (2007). Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. Journal of Hepatology. 46(6). 1055–1063. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026